--Must See--

Bioinformatics Summer Internship 2024 With Hands-On-Training + Project / Dissertation - 30 Days, 3 Months & 6 Months Duration

Wistar Institute and Plumbline Life Science Announce Partnership for Animal Health and Welfare

The Wistar Institute, an international biomedical research leader in cancer, immunology and infectious diseases, and Plumbline Life Sciences, Inc., an independent South Korean biotechnology company focused on animal health, are pleased to announce a partnership that leverages Wistar’s cutting-edge vaccine research and Plumbline’s expertise developing animal treatments and vaccines.

Cancer is not just a human disease. Animals are affected as well, with 50 percent of all pets dying from cancer-related complications each year. Pet owners are seeking therapeutic options for animals they have bonded with and consider part of the family. Now research advances are resulting in cancer and infectious disease treatments that were traditionally not an option for animals.

We are excited to apply our research advances in vaccine development for humans to improve treatments against disease in companion animals,” said David Weiner, Ph.D., Wistar executive vice president, director of the Vaccine Center, and the W.W. Smith Charitable Trust Professorship for Cancer Research. “As our research progresses, we believe there is the potential to advance the science into a successful product.”

Kyoon Andrew Kim, CFO of Plumbline Life Sciences, Inc. added,“David’s achievements in the development and creation of vaccines generates such potential for Plumbline’s efforts to reduce animal disease and death. We look forward to building a strong partnership and saving animal lives though the development of promising vaccines.

Heather A. Steinman, Ph.D., MBA, Wistar’s vice president for Business Development and executive director of Technology Transfer stated that they were pleased to be working with Plumbline and that “Partnerships with good people and enterprises are fundamental to accelerating the pace of moving Wistar discoveries from ‘bench to bedside’ and we take the long-term view on how our research—and the right partnerships—can make a positive societal impact through better treatments and breakthrough therapies for people and animals alike.”

Vennila is one of BioTecNika's Online Editors. When she is not posting news articles and jobs on the website, she can be found gardening or running off to far flung places for the next adventure, armed with a good book and mosquito repellant. Stalk her on her social networks to see what she does next.